Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Is Yesterday’s USDX Decline About to Trigger PMs Rally?

Although its decline was not yet significant, the USD Index finally declined yesterday. Given the recent breakout above the November 2019 highs, this move lower might leave one with mixed feelings. The USDX in the Short Run On one hand, the USD Index just closed abov...
Przemyslaw Radomski, CFA | February 12, 2020 |

Crucial number for silver owners

Six years ago, on January 15, 2004, I officially recommended silver for readers of my Weber Global Opportunities Report. We'd had silver stocks, and I'd owned silver personally, but I was waiting for silver to fall in order to get in at a better price for the news...
Chris Weber | October 28, 2012 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |

Mar 14th 2020, Silver Chartbook – Feeling Good

Feeling Good All engines stop. After a week like the last, it is important to exit the fright train. Bombarded by news that leave you at best concerned but more likely rather frightened, it is key to change ones state. No good decisions are made from a low energy stat...
Korbinian Koller | March 31, 2020 |

NIO, Rock Tech Lithium, Volkswagen: Forget hydrogen!

The pandemic shows it: humans are social creatures who long for their loved ones and want to experience something in good company. Mobility is the key to this. In the face of climate change and air pollution, electric cars are an obvious solution. But if you look at the stock ...
Nico Popp | February 18, 2021 |

Buzz on the Bullboards: The Rebound Season?

As soon as American Thanksgiving passes, the mood in North American markets shifts dramatically. Investors start to contend with holidays, gifts, and vacations on one hand, and the end of their fiscal years on the other. Companies also look to end the calendar year on a po...
Omri Wallach | December 4, 2019 |

The Die Is Cast

One of my good friends from the 1980s and 1990s was the late Ian McAvity, a superb technical analyst, a founder of Central Fund of Canada, a Bay Street Mover and, most importantly, a humble and thoroughly enjoyable man. He was the first newsletter writer that I came acros...
Streetwise Reports | February 25, 2020 |

Klondike Golden Moments

Foreword: This tale grew from a chance nugget discovery along the shore of a humble Yukon creek carving through the remote Territory and became the great history of the Klondike Gold Rush. Join author James Kwantes as he touches down in the Yukon with 12 exciting stories and c...
James Kwantes | August 15, 2019 |